Cargando…
Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
BACKGROUND: Research gaps exist on the use of medications for opioid use disorder (OUD) among birthing people. METHODS: This retrospective cohort study included people who underwent childbirth deliveries during 2017-2020 and had a diagnosis of OUD identified from a national private insurance claims...
Autores principales: | Wang, Xi, Meisel, Zachary, Kellom, Katherine, Whitaker, Jennifer, Strane, Douglas, Chatterjee, Anyun, Rosenquist, Rebecka, Matone, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690545/ https://www.ncbi.nlm.nih.gov/pubmed/38045493 http://dx.doi.org/10.1016/j.dadr.2023.100206 |
Ejemplares similares
-
Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022) -
Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023) -
Association of Health Insurance, Geography, and Race and Ethnicity With Disparities in Receipt of Recommended Postpartum Care in the US
por: Interrante, Julia D., et al.
Publicado: (2022) -
Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023) -
The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)